Cargando…

Metabolomics Identifies Biomarker Pattern for Early Diagnosis of Hepatocellular Carcinoma: from Diethylnitrosamine Treated Rats to Patients

Early diagnosis of hepatocellular carcinoma (HCC) remains challenging to date. Characteristic metabolic deregulations of HCC may enable novel biomarkers discovery for early diagnosis. A capillary electrophoresis-time of flight mass spectrometry (CE-TOF/MS)-based metabolomics approach was performed t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zeng, Jun, Huang, Xin, Zhou, Lina, Tan, Yexiong, Hu, Chunxiu, Wang, Xiaomei, Niu, Junqi, Wang, Hongyang, Lin, Xiaohui, Yin, Peiyuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4630653/ https://www.ncbi.nlm.nih.gov/pubmed/26526930 http://dx.doi.org/10.1038/srep16101

Ejemplares similares

A New Strategy for Analyzing Time-Series Data Using Dynamic Networks: Identifying Prospective Biomarkers of Hepatocellular Carcinoma
por: Huang, Xin, et al.
Publicado: (2016)

A Large‐scale, multicenter serum metabolite biomarker identification study for the early detection of hepatocellular carcinoma
por: Luo, Ping, et al.
Publicado: (2018)

Serum metabolome and targeted bile acid profiling reveals potential novel biomarkers for drug-induced liver injury
por: Ma, Zhenhua, et al.
Publicado: (2019)

A Computational Method of Defining Potential Biomarkers based on Differential Sub-Networks
por: Huang, Xin, et al.
Publicado: (2017)

A weighted relative difference accumulation algorithm for dynamic metabolomics data: long-term elevated bile acids are risk factors for hepatocellular carcinoma
por: Zhang, Weijian, et al.
Publicado: (2015)

Maotai Ameliorates Diethylnitrosamine-Initiated Hepatocellular Carcinoma Formation in Mice
por: Yi, Xu, et al.
Publicado: (2014)

A Modified Protocol of Diethylnitrosamine Administration in Mice to Model Hepatocellular Carcinoma
por: Memon, Azra, et al.
Publicado: (2020)

Accumulation of cholesterol, triglycerides and ceramides in hepatocellular carcinomas of diethylnitrosamine injected mice
por: Haberl, Elisabeth M., et al.
Publicado: (2021)

Multi-stress accelerated liver cancer progression in rats treated with diethylnitrosamine
por: Wang, Yan-Jiao, et al.
Publicado: (2021)

High-saturate-fat diet delays initiation of diethylnitrosamine-induced hepatocellular carcinoma
por: Duan, Xiao-Yan, et al.
Publicado: (2014)

Chronic Administration of Diethylnitrosamine and 2-Acetylaminofluorene Induces Hepatocellular Carcinoma in Wistar Rats
por: Sánchez-Meza, Jaime, et al.
Publicado: (2023)

Potential of siRNA-Bearing Subtilosomes in the Treatment of Diethylnitrosamine-Induced Hepatocellular Carcinoma
por: Jamal, Fauzia, et al.
Publicado: (2023)

Expression of Intercellular Adhesion Molecule-1 in the Livers of Rats Treated with Diethylnitrosamine
por: Matsuoka, Shunichi, et al.
Publicado: (2009)

Identification of the Potential Metabolic Pathways Involved in the Hepatic Tumorigenesis of Rat Diethylnitrosamine-Induced Hepatocellular Carcinoma via (1)H NMR-Based Metabolomic Analysis
por: Chen, Minjiang, et al.
Publicado: (2019)

Multi-TGDR, a multi-class regularization method, identifies the metabolic profiles of hepatocellular carcinoma and cirrhosis infected with hepatitis B or hepatitis C virus
por: Tian, Suyan, et al.
Publicado: (2014)

Tissue metabolomics identified new biomarkers for the diagnosis and prognosis prediction of pancreatic cancer
por: Liu, Chang, et al.
Publicado: (2022)

Deletion of sphingosine kinase 1 inhibits liver tumorigenesis in diethylnitrosamine-treated mice
por: Chen, Jinbiao, et al.
Publicado: (2018)

Systematic revelation of the protective effect and mechanism of Cordycep sinensis on diethylnitrosamine-induced rat hepatocellular carcinoma with proteomics
por: Wang, Pei-Wen, et al.
Publicado: (2016)

Pharmacokinetic herb-drug interactions between Aidi injection and doxorubicin in rats with diethylnitrosamine-induced hepatocellular carcinoma
por: Lu, Yuan, et al.
Publicado: (2021)

CD24–p53 axis suppresses diethylnitrosamine-induced hepatocellular carcinogenesis by sustaining intrahepatic macrophages
por: Li, Dongling, et al.
Publicado: (2018)

β-Catenin Loss in Hepatocytes Promotes Hepatocellular Cancer after Diethylnitrosamine and Phenobarbital Administration to Mice
por: Awuah, Prince Kwaku, et al.
Publicado: (2012)

Pharmacokinetics and Tissue Distribution Study of Caudatin in Normal and Diethylnitrosamine-Induced Hepatocellular Carcinoma Model Rats
por: Peng, Yunru, et al.
Publicado: (2015)

Protective Effect of Daidzein against Diethylnitrosamine/Carbon Tetrachloride-Induced Hepatocellular Carcinoma in Male Rats
por: Bashandy, Samir A. E., et al.
Publicado: (2023)

Metabolic Reprogramming and Risk Stratification of Hepatocellular Carcinoma Studied by Using Gas Chromatography–Mass Spectrometry-Based Metabolomics
por: Fang, Chengnan, et al.
Publicado: (2022)

Assessment of SENP3-interacting proteins in hepatocytes treated with diethylnitrosamine by BioID assay
por: Chen, Fei, et al.
Publicado: (2021)

Hepatoprotective effects of aspirin on diethylnitrosamine-induced hepatocellular carcinoma in rats by reducing inflammation levels and PD-L1 expression
por: Wang, Yikai, et al.
Publicado: (2023)

Metabolomic profiling identifies novel biomarkers and mechanisms in human bladder cancer treated with submucosal injection of gemcitabine
por: Yang, Chao, et al.
Publicado: (2019)

Modulatory Role of Shorea robusta Bark on Glucose-metabolizing Enzymes in Diethylnitrosamine Induced Hepatocellular Carcinoma in Rats
por: Kalaiselvan, A., et al.
Publicado: (2015)

Dietary restriction protects against diethylnitrosamine-induced hepatocellular tumorigenesis by restoring the disturbed gene expression profile
por: Duan, Ting, et al.
Publicado: (2017)

Effect of protocatechuic acid-layered double hydroxide nanoparticles on diethylnitrosamine/phenobarbital-induced hepatocellular carcinoma in mice
por: Gani, Shafinaz Abd, et al.
Publicado: (2019)

Gehua Jiecheng Decoction Inhibits Diethylnitrosamine-Induced Hepatocellular Carcinoma in Mice by Improving Tumor Immunosuppression Microenvironment
por: Cheng, Changpei, et al.
Publicado: (2020)

Curcumae Ameliorates Diethylnitrosamine-Induced Hepatocellular Carcinoma via Alteration of Oxidative Stress, Inflammation and Gut Microbiota
por: Zhang, Yunyan, et al.
Publicado: (2021)

Molecular Changes Following Induction of Hepatocellular Carcinoma by Diethylnitrosamine and Thioacetamide, and Subsequent Treatment with Dioscorea membranacea Extract
por: Kerdput, Vichununt, et al.
Publicado: (2022)

Deciphering hepatocellular carcinoma through metabolomics: from biomarker discovery to therapy evaluation
por: Guo, Wei, et al.
Publicado: (2018)

Serum Metabolomics to Identify the Liver Disease-Specific Biomarkers for the Progression of Hepatitis to Hepatocellular Carcinoma
por: Gao, Rong, et al.
Publicado: (2015)

Metabolomics study identified bile acids as potential biomarkers for gastric cancer: A case control study
por: Pan, Chen, et al.
Publicado: (2022)

Anti-cancer effects of Ajwa dates (Phoenix dactylifera L.) in diethylnitrosamine induced hepatocellular carcinoma in Wistar rats
por: Khan, Fazal, et al.
Publicado: (2017)

Overexpression of Hepatocyte Chemerin-156 Lowers Tumor Burden in a Murine Model of Diethylnitrosamine-Induced Hepatocellular Carcinoma
por: Haberl, Elisabeth M., et al.
Publicado: (2019)

Identifying therapeutic biomarkers of zoledronic acid by metabolomics
por: Li, Xiang, et al.
Publicado: (2023)

Enzyme studies of the liver of rats during carcinogenesis by diethylnitrosamine.
por: Hoch-Ligeti, C., et al.
Publicado: (1966)

Cannot write session to /tmp/vufind_sessions/sess_215ch6mbkplepo9u85jcaq9rcl